mozay22/clincal_bert_large_code_mapping · Datasets at Hugging Face

frequency int64 1 472k	HCPCS_Cd stringlengths 5 5	HCPCS_Desc stringlengths 4 256	rn float64 1 1
3	A9521	Technetium tc-99m exametazime, diagnostic, per study dose, up to 25 millicuries	1
40	A9526	Nitrogen n-13 ammonia, diagnostic, per study dose, up to 40 millicuries	1
48	A9538	Technetium tc-99m pyrophosphate, diagnostic, per study dose, up to 25 millicuries	1
2,351	A9552	Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries	1
1,088	A9555	Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries	1
2,739	A9575	Injection, gadoterate meglumine, 0.1 ml	1
268	A9576	Injection, gadoteridol, (prohance multipack), per ml	1
146	A9581	Injection, gadoxetate disodium, 1 ml	1
3	A9582	Iodine i-123 iobenguane, diagnostic, per study dose, up to 15 millicuries	1
130	A9584	Iodine 1-123 ioflupane, diagnostic, per study dose, up to 5 millicuries	1
2,982	A9585	Injection, gadobutrol, 0.1 ml	1
9	A9586	Florbetapir f18, diagnostic, per study dose, up to 10 millicuries	1
67	A9587	Gallium ga-68, dotatate, diagnostic, 0.1 millicurie	1
238	A9588	Fluciclovine f-18, diagnostic, 1 millicurie	1
9	A9589	Instillation, hexaminolevulinate hydrochloride, 100 mg	1
2	A9592	Copper cu-64, dotatate, diagnostic, 1 millicurie	1
31	A9597	Positron emission tomography radiopharmaceutical, diagnostic, for tumor identification, not otherwise classified	1
1	C1824	Generator, cardiac contractility modulation (implantable)	1
1	C1839	Iris prosthesis	1
8	C2639	Brachytherapy source, non-stranded, iodine-125, per source	1
2	C2641	Brachytherapy source, non-stranded, palladium-103, per source	1
5	C2643	Brachytherapy source, non-stranded, cesium-131, per source	1
7	C9046	Cocaine hydrochloride nasal solution for topical administration, 1 mg	1
2	C9250	Human plasma fibrin sealant, vapor-heated, solvent-detergent (artiss), 2 ml	1
382	C9290	Injection, bupivacaine liposome, 1 mg	1
5	C9399	Unclassified drugs or biologicals	1
33	C9600	Percutaneous transcatheter placement of drug eluting intracoronary stent(s), with coronary angioplasty when performed; single major coronary artery or branch	1
5	C9602	Percutaneous transluminal coronary atherectomy, with drug eluting intracoronary stent, with coronary angioplasty when performed; single major coronary artery or branch	1
2	C9604	Percutaneous transluminal revascularization of or through coronary artery bypass graft (internal mammary, free arterial, venous), any combination of drug-eluting intracoronary stent, atherectomy and angioplasty, including distal protection when performed;	1
2	C9728	Placement of interstitial device(s) for radiation therapy/surgery guidance (e.g., fiducial markers, dosimeter), for other than the following sites (any approach): abdomen, pelvis, prostate, retroperitoneum, thorax, single or multiple	1
1	C9739	Cystourethroscopy, with insertion of transprostatic implant; 1 to 3 implants	1
177	C9740	Cystourethroscopy, with insertion of transprostatic implant; 4 or more implants	1
7	C9752	Destruction of intraosseous basivertebral nerve, first two vertebral bodies, including imaging guidance (e.g., fluoroscopy), lumbar/sacrum	1
1	C9771	Nasal/sinus endoscopy, cryoablation nasal tissue(s) and/or nerve(s), unilateral or bilateral	1
1	D7140	Extraction, erupted tooth or exposed root (elevation and/or forceps removal)	1
3	E0746	Electromyography (emg), biofeedback device	1
29	G0068	Professional services for the administration of anti-infective, pain management, chelation, pulmonary hypertension, inotropic, or other intravenous infusion drug or biological (excluding chemotherapy or other highly complex drug or biological) for each inf	1
10	G0069	Professional services for the administration of subcutaneous immunotherapy or other subcutaneous infusion drug or biological for each infusion drug administration calendar day in the individual's home, each 15 minutes	1
15	G0070	Professional services for the administration of intravenous chemotherapy or other intravenous highly complex drug or biological infusion for each infusion drug administration calendar day in the individual's home, each 15 minutes	1
2	G0071	Payment for communication technology-based services for 5 minutes or more of a virtual (non-face-to-face) communication between an rural health clinic (rhc) or federally qualified health center (fqhc) practitioner and rhc or fqhc patient, or 5 minutes or m	1
1	G0077	Limited (30 minutes) care management home visit for a new patient. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility)	1
1	G0082	Limited (30 minutes) care management home visit for an existing patient. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility)	1
1	G0083	Moderate (45 minutes) care management home visit for an existing patient. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility)	1
6	G0088	Professional services, initial visit, for the administration of anti-infective, pain management, chelation, pulmonary hypertension, inotropic, or other intravenous infusion drug or biological (excluding chemotherapy or other highly complex drug or biologic	1
6	G0089	Professional services, initial visit, for the administration of subcutaneous immunotherapy or other subcutaneous infusion drug or biological for each infusion drug administration calendar day in the individual's home, each 15 minutes	1
8	G0090	Professional services, initial visit, for the administration of intravenous chemotherapy or other highly complex infusion drug or biological for each infusion drug administration calendar day in the individual's home, each 15 minutes	1
24	G0104	Colorectal cancer screening; flexible sigmoidoscopy	1
8,571	G0105	Colorectal cancer screening; colonoscopy on individual at high risk	1
1,310	G0108	Diabetes outpatient self-management training services, individual, per 30 minutes	1
3,106	G0127	Trimming of dystrophic nails, any number	1
10	G0130	Single energy x-ray absorptiometry (sexa) bone density study, one or more sites; appendicular skeleton (peripheral) (e.g., radius, wrist, heel)	1
90	G0249	Provision of test materials and equipment for home inr monitoring of patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; includes: provision of materials for use in the	1
909	G0260	Injection procedure for sacroiliac joint; provision of anesthetic, steroid and/or other therapeutic agent, with or without arthrography	1
2,391	G0268	Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing	1
118	G0270	Medical nutrition therapy; reassessment and subsequent intervention(s) following second referral in same year for change in diagnosis, medical condition or treatment regimen (including additional hours needed for renal disease), individual, face to face wi	1
70	G0277	Hyperbaric oxygen under pressure, full body chamber, per 30 minute interval	1
10,979	G0279	Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066)	1
836	G0296	Counseling visit to discuss need for lung cancer screening using low dose ct scan (ldct) (service is for eligibility determination and shared decision making)	1
62	G0339	Image-guided robotic linear accelerator-based stereotactic radiosurgery, complete course of therapy in one session or first session of fractionated treatment	1
93	G0340	Image-guided robotic linear accelerator-based stereotactic radiosurgery, delivery including collimator changes and custom plugging, fractionated treatment, all lesions, per session, second through fifth sessions, maximum five sessions per course of treatme	1
405	G0396	Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes	1
69	G0398	Home sleep study test (hst) with type ii portable monitor, unattended; minimum of 7 channels: eeg, eog, emg, ecg/heart rate, airflow, respiratory effort and oxygen saturation	1
1,337	G0399	Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation	1
125	G0400	Home sleep test (hst) with type iv portable monitor, unattended; minimum of 3 channels	1
13,177	G0402	Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment	1
165	G0406	Follow-up inpatient consultation, limited, physicians typically spend 15 minutes communicating with the patient via telehealth	1
263	G0407	Follow-up inpatient consultation, intermediate, physicians typically spend 25 minutes communicating with the patient via telehealth	1
208	G0408	Follow-up inpatient consultation, complex, physicians typically spend 35 minutes communicating with the patient via telehealth	1
1	G0409	Social work and psychological services, directly relating to and/or furthering the patient's rehabilitation goals, each 15 minutes, face-to-face; individual (services provided by a corf-qualified social worker or psychologist in a corf)	1
1	G0410	Group psychotherapy other than of a multiple-family group, in a partial hospitalization setting, approximately 45 to 50 minutes	1
5	G0413	Percutaneous skeletal fixation of posterior pelvic bone fracture and/or dislocation, for fracture patterns which disrupt the pelvic ring, unilateral or bilateral, (includes ilium, sacroiliac joint and/or sacrum)	1
2	G0414	Open treatment of anterior pelvic bone fracture and/or dislocation for fracture patterns which disrupt the pelvic ring, unilateral or bilateral, includes internal fixation when performed (includes pubic symphysis and/or superior/inferior rami)	1
2,390	G0416	Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method	1
80	G0420	Face-to-face educational services related to the care of chronic kidney disease; individual, per session, per one hour	1
40	G0422	Intensive cardiac rehabilitation; with or without continuous ecg monitoring with exercise, per session	1
40	G0423	Intensive cardiac rehabilitation; with or without continuous ecg monitoring; without exercise, per session	1
555	G0425	Telehealth consultation, emergency department or initial inpatient, typically 30 minutes communicating with the patient via telehealth	1
537	G0426	Telehealth consultation, emergency department or initial inpatient, typically 50 minutes communicating with the patient via telehealth	1
323	G0427	Telehealth consultation, emergency department or initial inpatient, typically 70 minutes or more communicating with the patient via telehealth	1
3	G0435	Infectious agent antibody detection by rapid antibody test, hiv-1 and/or hiv-2, screening	1
97,774	G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	1
8,235	G0442	Annual alcohol misuse screening, 15 minutes	1
28	G0443	Brief face-to-face behavioral counseling for alcohol misuse, 15 minutes	1
23,295	G0444	Annual depression screening, 15 minutes	1
22	G0445	High intensity behavioral counseling to prevent sexually transmitted infection; face-to-face, individual, includes: education, skills training and guidance on how to change sexual behavior; performed semi-annually, 30 minutes	1
2,921	G0446	Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes	1
3,118	G0447	Face-to-face behavioral counseling for obesity, 15 minutes	1
9	G0451	Development testing, with interpretation and report, per standardized instrument form	1
480	G0453	Continuous intraoperative neurophysiology monitoring, from outside the operating room (remote or nearby), per patient, (attention directed exclusively to one patient) each 15 minutes (list in addition to primary procedure)	1
39	G0459	Inpatient telehealth pharmacologic management, including prescription, use, and review of medication with no more than minimal medical psychotherapy	1
680	G0472	Hepatitis c antibody screening, for individual at high risk and other covered indication(s)	1
80	G0475	Hiv antigen/antibody, combination assay, screening	1
107	G0476	Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test	1
1,394	G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms	1
1,552	G0481	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms	1
1,579	G0482	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms	1
1,259	G0483	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms	1
886	G0498	Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l	1
17	G0499	Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when perfor	1
3,560	G0500	Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito	1

3

A9521

Technetium tc-99m exametazime, diagnostic, per study dose, up to 25 millicuries

1

40

A9526

Nitrogen n-13 ammonia, diagnostic, per study dose, up to 40 millicuries

1

48

A9538

Technetium tc-99m pyrophosphate, diagnostic, per study dose, up to 25 millicuries

1

2,351

A9552

Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries

1

1,088

A9555

Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries

1

2,739

A9575

Injection, gadoterate meglumine, 0.1 ml

1

268

A9576

Injection, gadoteridol, (prohance multipack), per ml

1

146

A9581

Injection, gadoxetate disodium, 1 ml

1

3

A9582

Iodine i-123 iobenguane, diagnostic, per study dose, up to 15 millicuries

1

130

A9584

Iodine 1-123 ioflupane, diagnostic, per study dose, up to 5 millicuries

1

2,982

A9585

Injection, gadobutrol, 0.1 ml

1

9

A9586

Florbetapir f18, diagnostic, per study dose, up to 10 millicuries

1

67

A9587

Gallium ga-68, dotatate, diagnostic, 0.1 millicurie

1

238

A9588

Fluciclovine f-18, diagnostic, 1 millicurie

1

9

A9589

Instillation, hexaminolevulinate hydrochloride, 100 mg

1

2

A9592

Copper cu-64, dotatate, diagnostic, 1 millicurie

1

31

A9597

Positron emission tomography radiopharmaceutical, diagnostic, for tumor identification, not otherwise classified

1

C1824

Generator, cardiac contractility modulation (implantable)

1

C1839

Iris prosthesis

1

8

C2639

Brachytherapy source, non-stranded, iodine-125, per source

1

2

C2641

Brachytherapy source, non-stranded, palladium-103, per source

1

5

C2643

Brachytherapy source, non-stranded, cesium-131, per source

1

7

C9046

Cocaine hydrochloride nasal solution for topical administration, 1 mg

1

2

C9250

Human plasma fibrin sealant, vapor-heated, solvent-detergent (artiss), 2 ml

1

382

C9290

Injection, bupivacaine liposome, 1 mg

1

5

C9399

Unclassified drugs or biologicals

1

33

C9600

Percutaneous transcatheter placement of drug eluting intracoronary stent(s), with coronary angioplasty when performed; single major coronary artery or branch

1

5

C9602

Percutaneous transluminal coronary atherectomy, with drug eluting intracoronary stent, with coronary angioplasty when performed; single major coronary artery or branch

1

2

C9604

Percutaneous transluminal revascularization of or through coronary artery bypass graft (internal mammary, free arterial, venous), any combination of drug-eluting intracoronary stent, atherectomy and angioplasty, including distal protection when performed;

1

2

C9728

Placement of interstitial device(s) for radiation therapy/surgery guidance (e.g., fiducial markers, dosimeter), for other than the following sites (any approach): abdomen, pelvis, prostate, retroperitoneum, thorax, single or multiple

1

C9739

Cystourethroscopy, with insertion of transprostatic implant; 1 to 3 implants

1

177

C9740

Cystourethroscopy, with insertion of transprostatic implant; 4 or more implants

1

7

C9752

Destruction of intraosseous basivertebral nerve, first two vertebral bodies, including imaging guidance (e.g., fluoroscopy), lumbar/sacrum

1

C9771

Nasal/sinus endoscopy, cryoablation nasal tissue(s) and/or nerve(s), unilateral or bilateral

1

D7140

Extraction, erupted tooth or exposed root (elevation and/or forceps removal)

1

3

E0746

Electromyography (emg), biofeedback device

1

29

G0068

Professional services for the administration of anti-infective, pain management, chelation, pulmonary hypertension, inotropic, or other intravenous infusion drug or biological (excluding chemotherapy or other highly complex drug or biological) for each inf

1

10

G0069

Professional services for the administration of subcutaneous immunotherapy or other subcutaneous infusion drug or biological for each infusion drug administration calendar day in the individual's home, each 15 minutes

1

15

G0070

Professional services for the administration of intravenous chemotherapy or other intravenous highly complex drug or biological infusion for each infusion drug administration calendar day in the individual's home, each 15 minutes

1

2

G0071

Payment for communication technology-based services for 5 minutes or more of a virtual (non-face-to-face) communication between an rural health clinic (rhc) or federally qualified health center (fqhc) practitioner and rhc or fqhc patient, or 5 minutes or m

1

G0077

Limited (30 minutes) care management home visit for a new patient. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility)

1

G0082

Limited (30 minutes) care management home visit for an existing patient. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility)

1

G0083

Moderate (45 minutes) care management home visit for an existing patient. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility)

1

6

G0088

Professional services, initial visit, for the administration of anti-infective, pain management, chelation, pulmonary hypertension, inotropic, or other intravenous infusion drug or biological (excluding chemotherapy or other highly complex drug or biologic

1

6

G0089

Professional services, initial visit, for the administration of subcutaneous immunotherapy or other subcutaneous infusion drug or biological for each infusion drug administration calendar day in the individual's home, each 15 minutes

1

8

G0090

Professional services, initial visit, for the administration of intravenous chemotherapy or other highly complex infusion drug or biological for each infusion drug administration calendar day in the individual's home, each 15 minutes

1

24

G0104

Colorectal cancer screening; flexible sigmoidoscopy

1

8,571

G0105

Colorectal cancer screening; colonoscopy on individual at high risk

1

1,310

G0108

Diabetes outpatient self-management training services, individual, per 30 minutes

1

3,106

G0127

Trimming of dystrophic nails, any number

1

10

G0130

Single energy x-ray absorptiometry (sexa) bone density study, one or more sites; appendicular skeleton (peripheral) (e.g., radius, wrist, heel)

1

90

G0249

Provision of test materials and equipment for home inr monitoring of patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; includes: provision of materials for use in the

1

909

G0260

Injection procedure for sacroiliac joint; provision of anesthetic, steroid and/or other therapeutic agent, with or without arthrography

1

2,391

G0268

Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing

1

118

G0270

Medical nutrition therapy; reassessment and subsequent intervention(s) following second referral in same year for change in diagnosis, medical condition or treatment regimen (including additional hours needed for renal disease), individual, face to face wi

1

70

G0277

Hyperbaric oxygen under pressure, full body chamber, per 30 minute interval

1

10,979

G0279

Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066)

1

836

G0296

Counseling visit to discuss need for lung cancer screening using low dose ct scan (ldct) (service is for eligibility determination and shared decision making)

1

62

G0339

Image-guided robotic linear accelerator-based stereotactic radiosurgery, complete course of therapy in one session or first session of fractionated treatment

1

93

G0340

Image-guided robotic linear accelerator-based stereotactic radiosurgery, delivery including collimator changes and custom plugging, fractionated treatment, all lesions, per session, second through fifth sessions, maximum five sessions per course of treatme

1

405

G0396

Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes

1

69

G0398

Home sleep study test (hst) with type ii portable monitor, unattended; minimum of 7 channels: eeg, eog, emg, ecg/heart rate, airflow, respiratory effort and oxygen saturation

1

1,337

G0399

Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation

1

125

G0400

Home sleep test (hst) with type iv portable monitor, unattended; minimum of 3 channels

1

13,177

G0402

Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment

1

165

G0406

Follow-up inpatient consultation, limited, physicians typically spend 15 minutes communicating with the patient via telehealth

1

263

G0407

Follow-up inpatient consultation, intermediate, physicians typically spend 25 minutes communicating with the patient via telehealth

1

208

G0408

Follow-up inpatient consultation, complex, physicians typically spend 35 minutes communicating with the patient via telehealth

1

G0409

Social work and psychological services, directly relating to and/or furthering the patient's rehabilitation goals, each 15 minutes, face-to-face; individual (services provided by a corf-qualified social worker or psychologist in a corf)

1

G0410

Group psychotherapy other than of a multiple-family group, in a partial hospitalization setting, approximately 45 to 50 minutes

1

5

G0413

Percutaneous skeletal fixation of posterior pelvic bone fracture and/or dislocation, for fracture patterns which disrupt the pelvic ring, unilateral or bilateral, (includes ilium, sacroiliac joint and/or sacrum)

1

2

G0414

Open treatment of anterior pelvic bone fracture and/or dislocation for fracture patterns which disrupt the pelvic ring, unilateral or bilateral, includes internal fixation when performed (includes pubic symphysis and/or superior/inferior rami)

1

2,390

G0416

Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method

1

80

G0420

Face-to-face educational services related to the care of chronic kidney disease; individual, per session, per one hour

1

40

G0422

Intensive cardiac rehabilitation; with or without continuous ecg monitoring with exercise, per session

1

40

G0423

Intensive cardiac rehabilitation; with or without continuous ecg monitoring; without exercise, per session

1

555

G0425

Telehealth consultation, emergency department or initial inpatient, typically 30 minutes communicating with the patient via telehealth

1

537

G0426

Telehealth consultation, emergency department or initial inpatient, typically 50 minutes communicating with the patient via telehealth

1

323

G0427

Telehealth consultation, emergency department or initial inpatient, typically 70 minutes or more communicating with the patient via telehealth

1

3

G0435

Infectious agent antibody detection by rapid antibody test, hiv-1 and/or hiv-2, screening

1

97,774

G0439

Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit

1

8,235

G0442

Annual alcohol misuse screening, 15 minutes

1

28

G0443

Brief face-to-face behavioral counseling for alcohol misuse, 15 minutes

1

23,295

G0444

Annual depression screening, 15 minutes

1

22

G0445

High intensity behavioral counseling to prevent sexually transmitted infection; face-to-face, individual, includes: education, skills training and guidance on how to change sexual behavior; performed semi-annually, 30 minutes

1

2,921

G0446

Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes

1

3,118

G0447

Face-to-face behavioral counseling for obesity, 15 minutes

1

9

G0451

Development testing, with interpretation and report, per standardized instrument form

1

480

G0453

Continuous intraoperative neurophysiology monitoring, from outside the operating room (remote or nearby), per patient, (attention directed exclusively to one patient) each 15 minutes (list in addition to primary procedure)

1

39

G0459

Inpatient telehealth pharmacologic management, including prescription, use, and review of medication with no more than minimal medical psychotherapy

1

680

G0472

Hepatitis c antibody screening, for individual at high risk and other covered indication(s)

1

80

G0475

Hiv antigen/antibody, combination assay, screening

1

107

G0476

Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test

1

1,394

G0480

Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms

1

1,552

G0481

Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms

1

1,579

G0482

Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms

1

1,259

G0483

Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms

1

886

G0498

Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l

1

17

G0499

Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when perfor

1

3,560

G0500

Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito

1